Protein kinase C inhibitors: a patent review (2010 – present)

By Sobhia Masilamani Elizabeth   Grewal Baljinder K   Paul Matam Losery Stanly   Patel Jigneshkumar   Kaur Amandeep   Haokip Thongtinlal   Kokkula Alekhya  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 11, 2013-11 ,pp. : 1451-1468

Informa Healthcare

Access to resources Recommend Favorite

Mdm2 and MdmX inhibitors for the treatment of cancer: a patent review (2011 – present)

By Zak Krzysztof   Pecak Aleksandra   Rys Barbara   Wladyka Benedykt   Dömling Alexander   Weber Lutz   Holak Tad A   Dubin Grzegorz  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 425-448

Informa Healthcare

Access to resources Recommend Favorite

Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases

By  

Current Drug Targets, Vol. 17, Iss. 16, 2016-12 ,pp. : 1940-1962

Bentham Science Publishers

Access to resources Recommend Favorite

The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: a patent review

By Pinto Donald J P   Qiao Jennifer X   Knabb Robert M  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 6, 2012-06 ,pp. : 645-661

Informa Healthcare

Access to resources Recommend Favorite

Cyclooxygenase-2 inhibitors: a literature and patent review (2009 – 2010)

By Jawabrah Al-Hourani Baker   Sharma Sai Kiran   Suresh Mavanur   Wuest Frank  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1339-1432

Informa Healthcare

Access to resources Recommend Favorite